After a decade of growth, Allergy Therapeutics had developed a strong product pipeline including a recently approved vaccine for grasses allergy. The time was right for them to enter the US market. However, their brand and digital estate were holding them back.
The brand no longer reflected the scale and ambition of the business, or its focus on R&D. The digital estate was fragmented, and there was little to differentiate content for their diverse stakeholders. We set to work to give them the identity and messaging they needed to take their next step.
Working closely with senior management, we brought all the relevant stakeholders together for a brand ambition workshop. This helped us develop an effective working relationship and allowed us to identify the unique qualities that sets this business apart.
We identified four key attributes; delivering convenience, transforming lives, providing specialist expertise and putting people first. Equipped with this knowledge, we built a new brand platform, including vision, mission, brand proposition and key messages for each stakeholder group.
Our semi-abstract designs highlighted the transformational nature of the treatments. We also created a new photographic library focusing on three areas: the positive effect on patients; the role of the doctor; and the specialist expertise within the business. Not least, we developed a new strapline: "Discover More", which references their strong R&D heritage through a call to action.
Regulations state that content for healthcare professionals (HCPs) must be in a separate part of the site. So we created corporate sites just for investors, partners and potential employees. This allows us to focus our messaging and simplify the user journey. Dedicated marketing websites can now promote regional services and products to the right HCPs and patients.